Testing the Effect of Multiple Weight Management Modalities for Chronic Disease Risk Reduction in a Clinical Setting
NCT ID: NCT03998878
Last Updated: 2021-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2019-08-08
2021-12-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 1: To determine the feasibility of recruiting, retaining and maintaining the adherence participants in a randomized clinical trial testing 3 weight loss modalities.
Aim 2: To examine and compare the effect of 3 weight loss modalities on changes in anthropometric measures and metabolic and cancer-related health markers.
Aim 3: To evaluate and compare patients' perceived satisfaction with each weight loss modality.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-Carbohydrate Diet
Participants will be instructed to consume less than 30 grams of carbohydrates per day.
Low-Carbohydrate Diet
Participants will be instructed to follow a low-carbohydrate diet.
Intermittent Energy Restriction
Participants choose 2 non-consecutive days per week in which they will consume 500-650 calories.
Intermittent Energy Restriction
Participants will be instructed to follow intermittent energy restriction.
Hunger Training
Participants monitor their hunger symptoms and blood glucose, and eat only when blood glucose is below a certain threshold level.
Hunger Training
Participants will be instructed to follow Hunger Training.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low-Carbohydrate Diet
Participants will be instructed to follow a low-carbohydrate diet.
Intermittent Energy Restriction
Participants will be instructed to follow intermittent energy restriction.
Hunger Training
Participants will be instructed to follow Hunger Training.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18
* HbA1C \<8.0
* Fluent in English
Exclusion Criteria
* Pregnant, breast-feeding, or planning to become pregnant within 6 months
* A1C ≥ 8.0
* Taking an anti-obesity medication
* Insulin-dependence
* prior metabolic surgery
* current laparoscopic adjustable gastric band ("lap band") use
* Experience of substantial weight changes (±5 kg or ±10 lbs) in the past 3 months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arizona
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amit Algotar, MD, PhD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Arizona, Banner University Medical Center
Susan M Schembre, PhD, RD
Role: PRINCIPAL_INVESTIGATOR
University of Arizona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arizona
Tucson, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1903480167
Identifier Type: -
Identifier Source: org_study_id